|
1
|
Fisher B, Anderson S, Bryant J, Margolese
RG, Deutsch M, Fisher ER, Jeong JH and Wolmark N: Twenty-year
follow-up of a randomized trial comparing total mastectomy,
lumpectomy, and lumpectomy plus irradiation for the treatment of
invasive breast cancer. N Engl J Med. 347:1233–1241. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Veronesi U, Cascinelli N, Mariani L, Greco
M, Saccozzi R, Luini A, Aguilar M and Marubini E: Twenty-year
follow-up of a randomized study comparing breast-conserving surgery
with radical mastectomy for early breast cancer. N Engl J Med.
347:1227–1232. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Haffty BG, Reiss M, Beinfield M, Fischer
D, Ward B and McKhann C: Ipsilateral breast tumor recurrence as a
predictor of distant disease: Implications for systemic therapy at
the time of local relapse. J Clin Oncol. 14:52–57. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Komoike Y, Akiyama F, Iino Y, Ikeda T,
Akashi-Tanaka S, Ohsumi S, Kusama M, Sano M, Shin E, Suemasu K, et
al: Ipsilateral breast tumor recurrence (IBTR) after
breast-conserving treatment for early breast cancer: Risk factors
and impact on distant metastases. Cancer. 106:35–41. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wapnir IL, Anderson SJ, Mamounas EP, Geyer
CE Jr, Jeong JH, Tan-Chiu E, Fisher B and Wolmark N: Prognosis
after ipsilateral breast tumor recurrence and locoregional
recurrences in five national surgical adjuvant breast and bowel
project node-positive adjuvant breast cancer trials. J Clin Oncol.
24:2028–2037. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Anderson SJ, Wapnir I, Dignam JJ, Fisher
B, Mamounas EP, Jeong JH, Geyer CE Jr, Wickerham DL, Costantino JP
and Wolmark N: Prognosis after ipsilateral breast tumor recurrence
and locoregional recurrences in patients treated by
breast-conserving therapy in five national surgical adjuvant breast
and bowel project protocols of node-negative breast cancer. J Clin
Oncol. 27:2466–2473. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ishitobi M, Ohsumi S, Inaji H, Ohno S,
Shigematsu H, Akiyama F, Iwase T, Akashi-Tanaka S, Sato N,
Takahashi K and Oura S: Ipsilateral breast tumor recurrence (IBTR)
in patients with operable breast cancer who undergo
breast-conserving treatment after receiving neoadjuvant
chemotherapy: Risk factors of IBTR and validation of the MD
Anderson prognostic index. Cancer. 118:4385–4393. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kurtz JM, Spitalier JM, Amalric R,
Brandone H, Ayme Y, Jacquemier J, Hans D and Bressac C: The
prognostic significance of late local recurrence after
breast-conserving therapy. Int J Radiat Oncol Biol Phys. 18:87–93.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Elkhuizen PH, Hermans J, Leer JW and van
de Vijver MJ: Isolated late local recurrences with high mitotic
count and early local recurrences following breast-conserving
therapy are associated with increased risk on distant metastasis.
Int J Radiat Oncol Biol Phys. 50:387–396. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
van der Sangen MJ, van de Poll-Franse LV,
Roumen RM, Rutten HJ, Coebergh JW, Vreugdenhil G and Voogd AC: The
prognosis of patients with local recurrence more than five years
after breast conservation therapy for invasive breast carcinoma.
Eur J Surg Oncol. 32:34–38. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
van Laar C, van der Sangen MJ, Poortmans
PM, Nieuwenhuijzen GA, Roukema JA, Roumen RM, Tjan-Heijnen VC and
Voogd AC: Local recurrence following breast-conserving treatment in
women aged 40 years or younger: Trends in risk and the impact on
prognosis in a population-based cohort of 1143 patients. Eur J
Cancer. 49:3093–3101. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ishitobi M, Okumura Y, Arima N, Yoshida A,
Nakatsukasa K, Iwase T, Shien T, Masuda N, Tanaka S, Tanabe M, et
al: Breast cancer subtype and distant recurrence after ipsilateral
breast tumor recurrence. Ann Surg Oncol. 20:1886–1892. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Alkner S, Tang MH, Brueffer C, Dahlgren M,
Chen Y, Olsson E, Winter C, Baker S, Ehinger A, Rydén L, et al:
Contralateral breast cancer can represent a metastatic spread of
the first primary tumor: Determination of clonal relationship
between contralateral breast cancers using next-generation whole
genome sequencing. Breast Cancer Res. 17:1022015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ishitobi M, Okuno J, Kittaka N, Nakayama
T, Koyama H and Tamaki Y: Distant recurrence risk after late
ipsilateral breast tumor recurrence: Results of a retrospective,
single-institution study. Oncology. 89:269–274. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Umemura S, Kurosumi M, Moriya T, Oyama T,
Arihiro K, Yamashita H, Umekita Y, Komoike Y, Shimizu C, Fukushima
H, et al: Immunohistochemical evaluation for hormone receptors in
breast cancer: A practically useful evaluation system and handling
protocol. Breast Cancer. 13:232–235. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wolff AC, Hammond ME, Hicks DG, Dowsett M,
McShane LM, Allison KH, Allred DC, Bartlett JM, Bilous M,
Fitzgibbons P, et al: Recommendations for human epidermal growth
factor receptor 2 testing in breast cancer: American society of
clinical oncology/college of American pathologists clinical
practice guideline update. J Clin Oncol. 31:3997–4013. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pergolizzi S, Adamo V, Russi E,
Santacaterina A, Maisano R, Numico G, Palazzolo C, Ferraù F,
Settineri N, Altavilla G, et al: Prospective multicenter study of
combined treatment with chemotherapy and radiotherapy in breast
cancer women with the rare clinical scenario of ipsilateral
supraclavicular node recurrence without distant metastases. Int J
Radiat Oncol Biol Phys. 65:25–32. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ludwig C, Stoelben E and Hasse J:
Disease-free survival after resection of lung metastases in
patients with breast cancer. Eur J Surg Oncol. 29:532–535. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Voogd AC, van Tienhoven G, Peterse HL,
Crommelin MA, Rutgers EJ, van de Velde CJ, van Geel BN, Slot A,
Rodrigus PT, Jobsen JJ, et al: Local recurrence after breast
conservation therapy for early stage breast carcinoma: Detection,
treatment and outcome in 266 patients. Dutch study group on local
recurrence after breast conservation (BORST). Cancer. 85:437–446.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Early Breast Cancer Trialists'
Collaborative Group (EBCTCG): Effects of chemotherapy and hormonal
therapy for early breast cancer on recurrence and 15-year survival:
An overview of the randomised trials. Lancet. 365:1687–1717. 2005.
View Article : Google Scholar : PubMed/NCBI
|
